Digital Diagnostics vs Magentiq Eye (2026)
Two cleared devices that both remove a dependency on specialist availability, at different levels of autonomy. Digital Diagnostics issues a diabetic retinopathy diagnosis with no physician reading the image, which is the only such authorisation in the United States, backed by the best pivotal evidence design in this index with equity built into it. Magentiq assists an endoscopist who is present throughout, running inference locally between the scope and the monitor so video never leaves the room, with authorisation in three jurisdictions and an international multicentre trial behind it. The evidence bar scales with autonomy: a system that decides alone needs pivotal evidence in the population it will serve, and one that assists needs to show the clinician does better with it.
- It is the only United States authorised instance of a diagnosis made without a clinician reading the image, with the best pivotal evidence design in this index.
- Equity was an input to that trial design rather than a disclosure added afterwards.
- A reimbursement pathway exists for the workflow, which decides whether a primary care clinic runs the test at all.
- The device performs local inference between the scope and the monitor in real time, so no video leaves the procedure room.
- It holds authorisation in three jurisdictions maintained across product versions, which is harder than a single clearance.
- The trial design behind it is an international multicentre study, which addresses the variation that matters most in this procedure.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Digital Diagnostics and Magentiq Eye are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Digital Diagnostics | Magentiq Eye |
|---|---|---|
| Primary category | Diagnostics & Genomics | Radiology & Imaging AI |
| Founded | 2010 | 2014 |
| Headquarters | Coralville, Iowa, United States | Haifa, Israel |
| Website | digitaldiagnostics.com | magentiq.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Digital Diagnostics its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Magentiq Eye, Digital Diagnostics grades higher on Autonomy and Oversight Model, AI Governance and Bias Disclosure and Commercial Transparency. Its thinnest published disclosure sits on HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Magentiq Eye its top capability grade on AI Centrality, Clinical and Operational Evidence and FDA and Regulatory Status. Set against Digital Diagnostics, Magentiq Eye does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Its thinnest published disclosure sits on HIPAA and BAA Posture, Security Certifications and Trust Center and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Digital Diagnostics or Magentiq Eye?
The AI Health Index grades Digital Diagnostics higher than Magentiq Eye on every axis that separates them, Autonomy and Oversight Model, AI Governance and Bias Disclosure and Commercial Transparency. Magentiq Eye does not grade higher on any scored axis.
Where do Digital Diagnostics and Magentiq Eye differ most?
The widest separation the AI Health Index records between Digital Diagnostics and Magentiq Eye is on AI Governance and Bias Disclosure, where Digital Diagnostics grades A and Magentiq Eye grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Digital Diagnostics and Magentiq Eye grade the same?
The AI Health Index grades Digital Diagnostics and Magentiq Eye the same on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Digital Diagnostics and Magentiq Eye not disclosed?
At the last review, at least one of Digital Diagnostics and Magentiq Eye published thin or absent detail on HIPAA and BAA Posture, Security Certifications and Trust Center and Commercial Transparency. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.
Both are cleared devices operating at the point of care and both remove a dependency on specialist availability, but the autonomy differs: one issues a diagnosis with no clinician reading the image, the other assists an endoscopist who is present throughout. The evidence demanded should differ accordingly. Digital Diagnostics publishes no security attestation. Magentiq publishes no health privacy statement or business associate terms, though its local inference architecture removes much of what those would govern. Neither publishes pricing.